Results 141 to 150 of about 13,032 (188)

Distribution and efficacy of dolutegravir-based regimens in the main HIV outpatient care in Caracas, Venezuela. [PDF]

AIDS Res Ther
Alvarado-Bruzual MF, Mendoza-Merlo VA, Martinez-Torres JA, Guerra-Reyes LJ, Guevara RN, Carballo M, Redondo MC, Landaeta ME, Forero-Peña DA.   +8 more
europepmc   +1 more source

Multitargeted Aza-Arylcarboxamides for Neurodegenerative Diseases: Potent Histamine H₃ Receptor Ligands with Anticholinesterase and Metal-Chelating Activities. [PDF]

ACS Chem Neurosci
Lopes FB, Werner T, Bagatin IA, Stark H, Fernandes JPS.   +4 more
europepmc   +1 more source

Synthesis of 1-substituted-4-[4-(1H-indol-3-yl)butyl]piperazines

ARKIVOC, 2013
Linas Labanauskas, Rita Mazeikaite, Gintaras Urbelis, Olga Gedrimaite, Jurgis Sudzius, Inga Cikotiene   +5 more
doaj   +1 more source

Patient-derived organoids based on targeted biopsy of primary prostate cancer: development, identification, and drug screening. [PDF]

Ann Med
Qian J, Peng S, Gao J, Fu Y, Huang H, Wu C, Gan W, Qiu X, Guo H.   +8 more
europepmc   +1 more source

KRAS G12C inhibitors versus chemotherapy in second line and beyond in adults with advanced or metastatic non-small cell lung cancer (NSCLC) harbouring the KRAS G12C mutation. [PDF]

Cochrane Database Syst Rev
Noordhof A, Asmara OD, de Jong K, Gijtenbeek RG, Huitema YM, van Vollenhoven FH, Venmans BJ, Hendriks L, van Geffen WH.   +8 more
europepmc   +1 more source

Piperazine Citrate [PDF]

, 2020
openaire   +1 more source

Comparing and combining xevinapant with ATR and PARP inhibition for the radiosensitization of HPV-negative HNSCC cells. [PDF]

Sci Rep
Roehrle J, Perugachi-Heinsohn A, Gatzemeier F, Christiansen S, Petersen C, Rothkamm K, Betz C, Kriegs M, Zech HB, Rieckmann T.   +9 more
europepmc   +1 more source

Palbociclib in Combination with Endocrine Therapy in Patients with Metastatic Breast Cancer in a Real-World Population: Impact of Dose-Intensity, Dose Reductions and Cycle Delays on Efficacy. [PDF]

Curr Oncol
Coussirou J, Grenier J, Mege A, Arnaud A, De Crozals F, Bonnet E, Vazquez L.   +6 more
europepmc   +1 more source

Phase II single-arm study of palbociclib and cetuximab in anti-EGFR naïve patients with KRAS/NRAS/BRAF wild-type, metastatic colorectal cancer. [PDF]

Oncologist
Sorah JD, Moore DT, Reilley MJ, Salem ME, Triglianos T, McRee AJ, Lee MS, Sanoff HK, Somasundaram AS.   +8 more
europepmc   +1 more source

Prevalence and factors associated with hyperglycemia among children living with HIV on dolutegravir in Kabale district, southwestern Uganda. [PDF]

PLoS One
Idow LH, Nduhukire T, Ankunda S, Tumwesigire S, Nyeko F, Tumwine JK.   +5 more
europepmc   +1 more source